Immune Evasion in Malignant Tumors
5 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which of the following mechanisms is NOT a way that malignant tumors evade host immune responses?

  • Down-regulation of class I MHC expression on tumor cells
  • Production of tumor cell products that suppress anti-tumor immune responses
  • Induction of specific immunologic tolerance by tumor antigens
  • Expression of costimulators and class II MHC molecules on tumor cells (correct)
  • How can the downregulation of class I MHC expression on tumor cells help them evade the immune system?

  • It prevents the tumor cells from being recognized by natural killer (NK) cells.
  • It prevents the tumor cells from activating the complement pathway.
  • It prevents the tumor cells from being recognized by cytotoxic T lymphocytes (CTLs). (correct)
  • It prevents the tumor cells from expressing tumor-associated antigens.
  • How can the loss of expression of antigens that elicit immune responses help malignant tumors evade the immune system?

  • It prevents the tumor cells from expressing costimulators and class II MHC molecules.
  • It prevents the tumor cells from being recognized by cytotoxic T lymphocytes (CTLs). (correct)
  • It prevents the tumor cells from activating the complement pathway.
  • It prevents the tumor cells from being recognized by natural killer (NK) cells.
  • What role do costimulators and class II MHC molecules play in immune response to tumors?

    <p>They are required for the activation of T helper cells. (D)</p> Signup and view all the answers

    How can the products of tumor cells suppress anti-tumor immune responses?

    <p>All of the above. (D)</p> Signup and view all the answers

    Study Notes

    Immune Evasion Mechanisms in Malignant Tumors

    • Malignant tumors often evade or resist the host's immune system.
    • Reduced Class I MHC expression: Tumor cells may downregulate Class I MHC molecules, preventing cytotoxic T lymphocytes (CTLs) from recognizing and attacking them.
    • Loss of immunogenic antigens: Tumors may lose the expression of antigens that would normally trigger an immune response.
    • Lack of costimulators and Class II MHC: Tumor cells often fail to express costimulators or Class II MHC molecules, hindering the activation and differentiation of CTLs.
    • Immunosuppressive tumor products: Tumor cells can produce substances that suppress anti-tumor immune responses.
    • Induced immunologic tolerance: Tumor antigens can sometimes induce specific immunological tolerance, making the system less able to fight the tumor.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz explores the mechanisms by which malignant tumors evade the host's immune system. Key topics include reduced Class I MHC expression, loss of immunogenic antigens, and the production of immunosuppressive substances by tumor cells. Understanding these mechanisms is crucial for developing effective cancer immunotherapies.

    More Like This

    Immune evasion
    28 questions

    Immune evasion

    DelightfulPink avatar
    DelightfulPink
    Pathogen Immune Evasion Strategies Quiz
    39 questions
    Tumor immune evasion mechanisms
    10 questions
    Parasitology: Immune Evasion Mechanisms
    24 questions
    Use Quizgecko on...
    Browser
    Browser